Myeloid Leukemia In Remission: Disease Bioinformatics
Myeloid Leukemia is a type of leukemia affecting myeloid tissues. This disease is a clonal disorder caused by malignant transformation of a bone marrow-derived, self-renewing stem cell or progenitor. This leads to a decreased rate of self-destruction and aberrant differentiation causing an accumulation in the organs and bone marrow by these myeloid cells. The development of Myeloid Leukemia has been associated with many predisposition syndromes that are caused by chromosomal imbalances, DNA repair defects, altered protein synthesis and altered cytokine receptors or signal transduction pathways. Myreloid Leukemia is most often categorized as either Acute or Chronic Myeloid Leukemia. Once the blood is totally free of the abnormal cells and has normal levels of cells it is thought to be in remission.
Myeloid Leukemia In Remission Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Myeloid Leukemia In Remission below!
For more information on how to use Laverne, please read the How to Guide.
We have 2557 products for the study of Myeloid Leukemia In Remission that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.